CD2AP and polyarteritis nodosa: Despite reciprocal changes in expression, abnormal subcellular CD2AP distribution was observed in both models, suggesting that changes in the molecular interactions of CD2AP with other proteins rather than expression levels per se mediate kidney injury in response to PAN and adriamycin.